https://www.healio.com/news/primary-care/20221205/dapagliflozin-reduces-hospitalization-risk-in-adults-with-chronic-kidney-disease
0
0
12/5/22 at 10:26pm
Organization
Healio
Authors
The SGLT2 inhibitor dapagliflozin was associated with a reduced risk for hospitalization due to any cause in patients with chronic kidney disease with and without type 2 diabetes, according to a post hoc analysis of the DAPA-CKD trial. Previous data from the …
Create an account
or login to join the discussion